Conditions: Major Depressive Disorder
Keywords: Depression Lurasidone Latuda
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 48
Healthy volunteers: no

Brief summary:
Lurasidone HCl is a compound that is a candidate for the treatment of major depressive with mixed features.This clinical study is designed to test how well Lurasidone works to treat major depressive disorder with mixed features over time.

Detailed description:

Arms:
arm 1: Lurasidone 20, 40, or 60 mg/day flexibly dosed

Interventions: intervention 1: Lurasidone
Intervention descriptions: intervention 1: Lurasidone 20, 40, or 60 mg/day, orally, once daily (QD) in the evening, with a meal or within 30 minutes after eating, flexibly dosed

Protocol document: